Zomedica corp

Zomedica corp DEFAULT

Zomedica Corp.

Phoenix Drive
Suite
Ann Arbor, MI
United States

http://www.zomedica.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 19

Key Executives

NameTitlePayExercisedYear Born
Mr. Robert CohenCEO & DirectorkN/A
Ms. Ann Marie Cotter CPACFO & Sec.N/AN/A
Dr. Stephanie Laine Morley D.V.M., DVMConsultantkN/A
Mr. Bruk HerbstChief Commercial OfficerkN/A
Mr. Larry C. Heaton IIPresN/AN/A
Mr. Michael SchilkVP of SalesN/AN/AN/A
Mr. David EatonVP of MarketingN/AN/AN/A
Dr. William Carpenter MacArthurConsultantN/AN/A
Mr. Robert W. DiMarzoConsultantN/AN/A

Amounts are as of December 31, and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA, a diagnostic biosensor platform for the detection of thyroid disorders in dogs and cats, and adrenal disorders in dogs. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October Zomedica Corp. was founded in and is headquartered in Ann Arbor, Michigan.

Corporate Governance

Zomedica Corp.’s ISS Governance QualityScore as of N/A is N/A.The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy ofInstitutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Sours: https://finance.yahoo.com/quote/ZOM/profile/

Zomedica Corp.

Zomedica Corp. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. It offers products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Its TRUFORMA biosensor platform is designed to assist practitioners in the diagnosis of complex conditions. The company was founded by Gerald L. Solensky Jr. on January 7, and is headquartered in Ann Arbor, MI.

P/E CurrentN/A
P/E Ratio (w/ extraordinary items)N/A
P/E Ratio (w/o extraordinary items)N/A
Price to Sales RatioN/A
Price to Book Ratio
Price to Cash Flow RatioN/A
Enterprise Value to EBITDAN/A
Enterprise Value to SalesN/A
Total Debt to Enterprise Value
Revenue/EmployeeN/A
Income Per EmployeeeN/A
Receivables TurnoverN/A
Total Asset TurnoverN/A
Current Ratio
Quick Ratio
Cash Ratio
Gross MarginN/A
Operating MarginN/A
Pretax MarginN/A
Net MarginN/A
Return on Assets%
Return on Equity%
Return on Total Capital%
Return on Invested Capital%
Total Debt to Total Equity
Total Debt to Total Capital
Total Debt to Total Assets
Long-Term Debt to Equity
Long-Term Debt to Total Capital
Sours: https://www.marketwatch.com/investing/stock/zom/company-profile
  1. Fortnite faces skins
  2. Kingdom boatworks
  3. Moe banned from fortnite
  4. Sas sum column

Zomedica Corp

About Zomedica Corp

Zomedica Corp. is a veterinary health company creating products for companion animals by focusing on the unmet needs of clinical veterinarians. The Company is developing point-of-care diagnostic platform, which is based on miniaturized laser-based Raman spectroscopy technology and is designed to detect pathogens in companion animals. It offers TRUFORMA is a diagnostic biosensor platform and the first five assays for the detection of thyroid disorders in dogs and cats and adrenal disorders in dogs. The TRUFORMA platform uses bulk acoustic wave (BAW) technology to provide a non-optical and fluorescence free detection system for use at the point-of-care. The TRUFORMA also offers complete control over the testing process from start to finish, with sensitive and specific immunoassays that allow veterinarians to make clinical decisions.

Industry

Biotechnology & Drugs

Executive Leadership

Jeffrey Mark Rowe

Chairman of the Board

Robert Cohen

Chief Executive Officer, Director

Ann Cotter

Chief Financial Officer, Secretary

Stephanie Laine Morley

Chief Operating Officer

Key Stats

Price To Earnings (TTM)

--

Price To Sales (TTM)

16,

Price To Book (MRQ)

Price To Cash Flow (TTM)

--

Total Debt To Equity (MRQ)

LT Debt To Equity (MRQ)

Return on Investment (TTM)

Return on Equity (TTM)

Sours: https://www.reuters.com/companies/ZOM
Zomedica Pharmaceuticals Corp. (TSX-V: ZOM) (NYSE American: ZOM) - Stock News Now

.

Corp zomedica

.

Es Muy Tarde Para Comprar Zomedica $ZOM?? Creo Que Todavía Hay Tiempo..

.

You will also be interested:

.



407 408 409 410 411